FMACX
Price
$38.82
Change
-$2.08 (-5.09%)
Updated
Apr 3 closing price
Net Assets
83.26B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

FMACX vs GFACX

Header iconFMACX vs GFACX Comparison
Open Charts FMACX vs GFACXBanner chart's image
American Funds AMCAP F3
Price$38.82
Change-$2.08 (-5.09%)
VolumeN/A
Net Assets83.26B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
FMACX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMACX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMACX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. FMACX (83.3B). FMACX pays higher dividends than GFACX: FMACX (0.65) vs GFACX (0.00). FMACX was incepted earlier than GFACX: FMACX (8 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FMACX (0.34). FMACX is a more actively managed with annual turnover of: 27.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than FMACX: GFACX (250) vs FMACX (1000000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. FMACX (-2.78). GFACX return over 5 years is better than : 59.73 vs. FMACX (55.90).
FMACXGFACXFMACX / GFACX
Total Expense Ratio0.341.3625%
Annual Report Gross Expense Ratio0.341.3625%
Fund Existence8 years24 years-
Gain YTD-5.082-5.003102%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets83.3B280B30%
Annual Yield % from dividends0.650.00-
Returns for 1 year-2.78-1.75159%
Returns for 3 years2.200.63349%
Returns for 5 years55.9059.7394%
Returns for 10 yearsN/A44.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences